Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis

By Sabbatani Sergio   Manfredi Roberto   Marinacci Ginevra   Pavoni Michele   Cristoni Lorenzo   Chiodo Francesco  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 3, 2006-03 ,pp. : 205-208

Informa Healthcare

Access to resources Recommend Favorite

Early Viral Kinetics during Treatment of Chronic Hepatitis C Virus Infection with Pegylated Interferon Alpha plus Ribavirin in Taiwan

By  

Intervirology, Vol. 50, Iss. 4, 2007-07 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

The serum IL‐23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1549-1556

John Wiley & Sons Inc

Access to resources Recommend Favorite

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 254-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C

By Liu Ya-Li   Du Xiao-Fei   Chen Xin-Yue   Ma Li-Na   Guo Dan-Dan   Lu Jun-Feng   Cao Zhen-Huan   Zhang Yong-Hong  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 12, 2013-12 ,pp. : 939-943

Informa Healthcare

Access to resources Recommend Favorite